Biome Australia eyes best day on positive trial results for acne treatment

Biome Australia

09/02/2022 04:33

** The biotech service co  BIO.AX  rises as much as 15% to
A$0.115, set for its best intraday session 
    ** Biome Australia says an independent clinical trial result
proved that a targeted probiotic led to a 31.11% reduction in
acne lesions in four weeks, and a 38.89% reduction in 8 weeks
 urn:newsml:reuters.com:*:nASXbDTh7Q
    ** Co says it will launch Biome Acne Pro biotic for the
treatment of acne, representing opportunity for commercial
growth  
    ** Shares hit their highest levels since Feb 3 
    ** More than 566,700 shares change hands, as compared with
the 30-day average volume of ~326,200 shares  
    ** Stock down 16.7% this year, as of last close 
    

 (Reporting by Roushni Nair in Bengluru)
 ((Roushni.Nair@thomsonreuters.com;))